BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 26520622)

  • 21. Additional aberrations of the ETV6 and RUNX1 genes have no prognostic impact in 229 t(12;21)(p13;q22)-positive B-cell precursor acute lymphoblastic leukaemias treated according to the NOPHO-ALL-2000 protocol.
    Barbany G; Andersen MK; Autio K; Borgström G; Franco LC; Golovleva I; Heim S; Heinonen K; Hovland R; Johansson B; Johannsson JH; Kjeldsen E; Nordgren A; Palmqvist L; Forestier E; ; ;
    Leuk Res; 2012 Jul; 36(7):936-8. PubMed ID: 22521551
    [No Abstract]   [Full Text] [Related]  

  • 22. Multiplex reverse transcription-polymerase chain reaction as diagnostic molecular screening of 4 common fusion chimeric genes in Taiwanese children with acute lymphoblastic leukemia.
    Yang YL; Lin SR; Chen JS; Hsiao CC; Lin KH; Sheen JM; Cheng CN; Wu KH; Lin SW; Yu SL; Chen HY; Lu MY; Chang HH; Yen CT; Lin JF; Su YH; Li YP; Lin CY; Jou ST; Lin DT
    J Pediatr Hematol Oncol; 2010 Nov; 32(8):e323-30. PubMed ID: 20930648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Minimal residual disease analysis in children with t(12;21)-positive acute lymphoblastic leukemia: comparison of Ig/TCR rearrangements and the genomic fusion gene.
    Metzler M; Mann G; Monschein U; Lodzinski M; Gall C; Flohr T; Viehmann S; Langer T; Schrappe M; Gadner H; Haas OA; Panzer-Grümayer ER
    Haematologica; 2006 May; 91(5):683-6. PubMed ID: 16627248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A patient with B-cell acute lymphoblastic leukemia with PAX5-ETV6 rearrangement with dic(9;12)(p13;p13) identified by chromosomal microarray.
    Ha J; Kim B; Hahn S; Lee ST; Lyu CJ; Choi JR
    Ann Hematol; 2018 Aug; 97(8):1505-1507. PubMed ID: 29520434
    [No Abstract]   [Full Text] [Related]  

  • 25. RUNX1 aberrations in ETV6/RUNX1-positive and ETV6/RUNX1-negative patients: its hemato-pathological and prognostic significance in a large cohort (619 cases) of ALL.
    Pais AP; Amare Kadam PS; Raje GC; Banavali S; Parikh P; Kurkure P; Arora B; Gujral S; Kumar SA; Badrinath Y
    Pediatr Hematol Oncol; 2008 Sep; 25(6):582-97. PubMed ID: 18728978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Copy number variations in pediatric ETV6/RUNX1 positive acute lymphoblastic leukemia].
    Zou Y; Zhang L; Liu X; Guo Y; Yang W; Zhang J; Liu F; Liu T; Wang S; Chen X; Ruan M; Qi B; Chang L; Chen Y; Zhu X
    Zhonghua Er Ke Za Zhi; 2016 Mar; 54(3):209-13. PubMed ID: 26957068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome of ETV6/RUNX1-positive childhood acute lymphoblastic leukaemia in the NOPHO-ALL-1992 protocol: frequent late relapses but good overall survival.
    Forestier E; Heyman M; Andersen MK; Autio K; Blennow E; Borgström G; Golovleva I; Heim S; Heinonen K; Hovland R; Johannsson JH; Kerndrup G; Nordgren A; Rosenquist R; Swolin B; Johansson B; ; ;
    Br J Haematol; 2008 Mar; 140(6):665-72. PubMed ID: 18241254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: an international collaborative study.
    Boer JM; van der Veer A; Rizopoulos D; Fiocco M; Sonneveld E; de Groot-Kruseman HA; Kuiper RP; Hoogerbrugge P; Horstmann M; Zaliova M; Palmi C; Trka J; Fronkova E; Emerenciano M; do Socorro Pombo-de-Oliveira M; Mlynarski W; Szczepanski T; Nebral K; Attarbaschi A; Venn N; Sutton R; Schwab CJ; Enshaei A; Vora A; Stanulla M; Schrappe M; Cazzaniga G; Conter V; Zimmermann M; Moorman AV; Pieters R; den Boer ML
    Leukemia; 2016 Jan; 30(1):32-8. PubMed ID: 26202931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concordant B-cell precursor acute lymphoblastic leukemia in non-twinned siblings.
    Pombo-de-Oliveira MS; Emerenciano M; Winn AP; Costa I; Mansur MB; Ford AM
    Blood Cells Mol Dis; 2015 Jan; 54(1):110-5. PubMed ID: 25150625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
    Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
    J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy and prognostic factors of the chemotherapy regimen of CCLG-ALL-2008 on pediatric acute lymphoblastic leukemia with ETV6-RUNX1 rearrangement].
    Liu F; Chen XJ; Guo Y; Yang WY; Chen X; Zhang XY; Zhang RR; Ren YY; Zhu XF
    Zhonghua Xue Ye Xue Za Zhi; 2020 Nov; 41(11):896-902. PubMed ID: 33333691
    [No Abstract]   [Full Text] [Related]  

  • 32. Rapid quantitative detection of TEL-AML1 fusion transcripts in pediatric acute lymphoblastic leukemia by real-time reverse transcription polymerase chain reaction using fluorescently labeled probes.
    Bolufer P; Barragán E; Verdeguer A; Cervera J; Fernández JM; Moreno I; Lerma E; Esquembre C; Tasso M; Fuster V; Bermúdez M; Sanz MA
    Haematologica; 2002 Jan; 87(1):23-32. PubMed ID: 11801462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PAX5-ESRRB is a recurrent fusion gene in B-cell precursor pediatric acute lymphoblastic leukemia.
    Marincevic-Zuniga Y; Zachariadis V; Cavelier L; Castor A; Barbany G; Forestier E; Fogelstrand L; Heyman M; Abrahamsson J; Lönnerholm G; Nordgren A; Syvänen AC; Nordlund J
    Haematologica; 2016 Jan; 101(1):e20-3. PubMed ID: 26494837
    [No Abstract]   [Full Text] [Related]  

  • 34. High frequency of intermediate and poor risk copy number abnormalities in pediatric cohort of B-ALL correlate with high MRD post induction.
    Singh M; Bhatia P; Trehan A; Varma N; Sachdeva MS; Bansal D; Jain R; Naseem S
    Leuk Res; 2018 Mar; 66():79-84. PubMed ID: 29407587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PAX5-AUTS2 fusion resulting from t(7;9)(q11.2;p13.2) can now be classified as recurrent in B cell acute lymphoblastic leukemia.
    Coyaud E; Struski S; Dastugue N; Brousset P; Broccardo C; Bradtke J
    Leuk Res; 2010 Dec; 34(12):e323-5. PubMed ID: 20723977
    [No Abstract]   [Full Text] [Related]  

  • 36. Autophagy inhibition as a potential future targeted therapy for ETV6-RUNX1-driven B-cell precursor acute lymphoblastic leukemia.
    Polak R; Bierings MB; van der Leije CS; Sanders MA; Roovers O; Marchante JRM; Boer JM; Cornelissen JJ; Pieters R; den Boer ML; Buitenhuis M
    Haematologica; 2019 Apr; 104(4):738-748. PubMed ID: 30381299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Favorable Trisomies and
    Mattano LA; Devidas M; Maloney KW; Wang C; Friedmann AM; Buckley P; Borowitz MJ; Carroll AJ; Gastier-Foster JM; Heerema NA; Kadan-Lottick NS; Matloub YH; Marshall DT; Stork LC; Loh ML; Raetz EA; Wood BL; Hunger SP; Carroll WL; Winick NJ
    J Clin Oncol; 2021 May; 39(14):1540-1552. PubMed ID: 33739852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120.
    Fazio G; Bresolin S; Silvestri D; Quadri M; Saitta C; Vendramini E; Buldini B; Palmi C; Bardini M; Grioni A; Rigamonti S; Galbiati M; Mecca S; Savino AM; Peloso A; Tu JW; Bhatia S; Borkhardt A; Micalizzi C; Lo Nigro L; Locatelli F; Conter V; Rizzari C; Valsecchi MG; Te Kronnie G; Biondi A; Cazzaniga G
    EBioMedicine; 2022 Sep; 83():104224. PubMed ID: 35985167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ETV6 (TEL)-AML1 pre-B acute lymphoblastic leukaemia cells are associated with a distinct antigen-presenting phenotype.
    Alessandri AJ; Reid GS; Bader SA; Massing BG; Sorensen PH; Schultz KR
    Br J Haematol; 2002 Feb; 116(2):266-72. PubMed ID: 11841426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of genetic alterations in children with first bone marrow relapse of childhood B-cell precursor acute lymphoblastic leukemia.
    Krentz S; Hof J; Mendioroz A; Vaggopoulou R; Dörge P; Lottaz C; Engelmann JC; Groeneveld TW; Körner G; Seeger K; Hagemeier C; Henze G; Eckert C; von Stackelberg A; Kirschner-Schwabe R
    Leukemia; 2013 Feb; 27(2):295-304. PubMed ID: 22699455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.